+1 (202) 780-33972nd International Conference on Hematology and Oncology
August 23-24, 2018 | London, UK
Posters & Accepted Abstracts
-
Chronic liver disease and hemostatic disturbances
Hematol Blood Disord
Olfat M Hendy -
Coagulation profile in Myeloproliferative Neoplasms
Hematol Blood Disord
Sadia Taj -
Diffuse Large B Cell Lymphoma and Clinical Intervention
Hematol Blood Disord
Ashok Srivastava -
FBXO11 is a frequently mutated oncosuppressor in Burkitt Lymphoma
Hematol Blood Disord
Roberto Chiarle -
Hemotopoietic toxicity and blood diseases induced by benzene exposure
Hematol Blood Disord
Cheng Peng -
Imbalanced proportions of phospatidylinositol and phosphatidylcholine in plasma membranes of hematopoietic cells in patients with paroxysmal nocturnal hemoglobinuria
Hematol Blood Disord
Jacek Nowak -
Intracellular oxidative stress contributes to the oncogenic potential of mutant FLT3 in acute myeloid leukaemia patients, and is a synergistic treatment target
Hematol Blood Disord
M D Dun -
In vitro culture of BM cells and CytB polymorphisms can predict the In-vivo Hematological response induced by deferasirox
Hematol Blood Disord
Muhammad Shahzad Ali -
Manifestation of Antiphospholipid Syndrome among Saudi patients; Examining the applicability of Sapporo
Hematol Blood Disord
Farjah H AlGahtani -
miRNAs Modulate Chemotherapeutic Sensitivity in a model of Acute Myeloid Leukemia
Hematol Blood Disord
Brian D Adams -
PICCs & Central Line Associated Blood Stream Infections in Aneurin Bevan Health Board
Hematol Blood Disord
Richard Fenton -
The Anti-Cancer Potential of Polyphenols in the Treatment of Leukemia
Hematol Blood Disord
Mahbub AA, Le Maitre CL and Haywood-Small SL